MARVIA MCDONALD-DIAS: Open Payments
NPI 1326765538 · WATERBURY, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,683 in 44 payments from 10 companies in 2025. Trend: 2023 $355 · 2024 $0 · 2025 $1,683
Food & beverage: $1,683
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $540 |
| Axsome Therapeutics, Inc. | 6 | $258 |
| Alkermes, Inc. | 7 | $252 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $205 |
| Otsuka America Pharmaceutical, Inc. | 3 | $176 |
| Indivior Inc. | 4 | $108 |
| Neurocrine BioSciences, Inc. | 2 | $55 |
| Braeburn Inc. | 1 | $31 |
| E.R. Squibb & Sons, L.L.C. | 1 | $31 |
| Vanda Pharmaceuticals Inc. | 1 | $28 |
Products named: VRAYLAR, Auvelity, CAPLYTA, REXULTI, ARISTADA, LYBALVI, SUBLOCADE, INGREZZA.
Industry payments across CT — which companies pay providers there.
